Neonatal desensitization for the study of regenerative medicine

Regenerative Medicine

Volumn 10, Issue 3, 2015, Pages 265-274

  Roberton, Victoria H ^a   Rosser, Anne E ^a,b   Kelly, Claire M ^c  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b CARDIFF UNIVERSITY   (United Kingdom)

^c CARDIFF METROPOLITAN UNIVERSITY   (United Kingdom)

Author keywords

cell replacement; desensitization; Huntington's disease; immunosuppression; rejection; rodent models; transplantation; xenograft

Indexed keywords

CYCLOSPORIN A;

ARTICLE; BRAIN NERVE CELL; CELL SURVIVAL; CELL THERAPY; CENTRAL NERVOUS SYSTEM DISEASE; DESENSITIZATION; FETUS CELL; GRAFT SURVIVAL; HUMAN; HUNTINGTON CHOREA; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; MOUSE; NEWBORN CARE; NONHUMAN; PARKINSON DISEASE; PATIENT SAFETY; PRIORITY JOURNAL; RAT; REGENERATIVE MEDICINE; SPECIES COMPARISON; TUMOR XENOGRAFT; XENOTRANSPLANTATION; ADULT; ANIMAL; CELL TRANSPLANTATION; FEMALE; IMMUNOSUPPRESSIVE TREATMENT; MALE; NEWBORN; PROCEDURES;

ADULT; ANIMALS; CELL TRANSPLANTATION; FEMALE; HUMANS; IMMUNOSUPPRESSION; INFANT, NEWBORN; MALE; RATS; REGENERATIVE MEDICINE;

EID: 84930011114     PISSN: 17460751     EISSN: 1746076X     Source Type: Journal    
DOI: 10.2217/rme.14.76     Document Type: Article

References (54)

1. Brundin P, Nilsson OG, Strecker RE, Lindvall O, Astedt B, Bjorklund A. Behavioural effects of human fetal dopamine neurons grafted in a rat model of Parkinson's disease. Exp. Brain Res. 65(1), 235-240 (1986).
2. Dunnett SB, Nathwani F, Björklund A. Chapter 16 The integration and function of striatal grafts. In: Progress in Brain Research. Dunnett SB, Björklund A (Eds.). Elsevier, Amsterdam, 345-380 (2000).
3. Nakao N, Itakura T. Fetal tissue transplants in animal models of Huntington's disease: the effects on damaged neuronal circuitry and behavioral deficits. Prog. Neurobiol. 61(3), 313-338 (2000).
4. Rosser AE, Bachoud-Lévi A-C. Clinical trials of neural transplantation in Huntington's disease. Prog. Brain Res. 200, 345-371 (2012).
5. Evans JR, Mason SL, Barker RA. Current status of clinical trials of neural transplantation in Parkinson's disease. Prog. Brain Res. 200, 169-198 (2012).
6. Rosser AE, Dunnett SB. Neural transplantation in Huntington's Disease. In: Cellular Transplantation: From Laboratory To Clinic Academic Press, Halberstadt C, Emerich D Burlington Burlington USA 417-437 (2007).
7. Barker RA, Mason SL, Harrower TP et al. The long-Term safety and efficacy of bilateral transplantation of human fetal striatal tissue in patients with mild to moderate Huntington's disease. J. Neurol. Neurosurg. Psychiatry 84(6), 657-665 (2013).
8. Hurelbrink CB, Armstrong RJ, Barker RA, Dunnett SB, Rosser AE. Hibernated human fetal striatal tissue: successful transplantation in a rat model of Huntington's disease. Cell Transplant. 9(6), 743-749 (2000).
9. Björklund A, Lindvall O. Cell replacement therapies for central nervous system disorders. Nat. Neurosci. 3, 537-544 (2000).
10. Kelly CM, Precious SV, Torres EM et al. Medical terminations of pregnancy: a viable source of tissue for cell replacement therapy for neurodegenerative disorders. Cell Transplant. 20(4), 503-513 (2011).
11. Kim SU, De Vellis J. Stem cell-based cell therapy in neurological diseases: a review. J. Neurosci. Res. 87, 2183-2200 (2009).
12. Precious SV, Rosser AE. Producing striatal phenotypes for transplantation in Huntington's disease. Exp. Biol. Med. 237(4), 343-351 (2012).
13. Galea I, Bechmann I, Perry VH. What is immune privilege (not)? Trends Immunol. 28(1), 12-18 (2007).
14. Barker RA, Ratcliffe E, McLaughlin M, Richards A, Dunnett SB. A role for complement in the rejection of porcine ventral mesencephalic xenografts in a rat model of Parkinson's disease. J. Neurosci. 20, 3415 (2000).
15. Kelly CM, Precious SV, Scherf C et al. Neonatal desensitization allows long-Term survival of neural xenotransplants without immunosuppression. Nature Methods 6, 271-273 (2009).
16. Jablonska A, Janowski M, Lukomska B. Different methods of immunosuppresion do not prolong the survival of human cord blood-derived neural stem cells transplanted into focal brain-injured immunocompetent rats. Acta Neurobiol. Exp. (Wars.) 73(1), 88-101 (2013).
17. Larsson LC, Frielingsdorf H, Mirza B et al. Porcine neural xenografts in rats and mice: donor tissue development and characteristics of rejection. Exp. Neurol. 172, 100-114 (2001).
18. Roberton VH, Evans AE, Harrison DJ et al. Is the adult mouse striatum a hostile host for neural transplant survival? Neuroreport 24(18), 1010-1015 (2013).
19. Al Nimer F, Wennersten AA, Holmin S, Meijer X, Wahlberg L, Mathiesen T. MHC expression after human neural stem cell transplantation to brain contused rats. NeuroReport 15, 1871-1875 (2004).
20. Bertani T, Perico N, Abbate M, Battaglia C, Remuzzi G. Renal injury induced by long-Term administration of cyclosporin A to rats. Am. J. Pathol. 127, 569-579 (1987).
21. Grasbon-Frodl E, Nakao N, Lindvall O, Brundin P. Phenotypic development of the human embryonic striatal primordium: a study of cultured and grafted neurons from the lateral and medial ganglionic eminences. Neuroscience 73(1), 171-183 (1996).
22. Grasbon-Frodl EM, Nakao N, Lindvall O, Brundin P. Developmental features of human striatal tissue transplanted in a rat model of Huntington's disease. Neurobiol. Dis. 3, 299-311 (1997).
23. Pearl JI, Lee AS, Leveson-Gower DB et al. Short-Term immunosuppression promotes engraftment of embryonic and induced pluripotent stem cells. Cell Stem Cell 8, 309-317 (2011).
24. Hurelbrink CB, Armstrong RJ, Dunnett SB, Rosser AE, Barker RA. Neural cells from primary human striatal xenografts migrate extensively in the adult rat CNS. Eur. J. Neurosci. 15(7), 1255-1266 (2002).
25. Hurelbrink CB, Barker RA. Migration of cells from primary transplants of allo-And xenografted foetal striatal tissue in the adult rat brain. Eur. J. Neurosci. 21, 1503-1510 (2005).
26. Nasonkin I, Mahairaki V, Xu L et al. Long-Term, stable differentiation of human embryonic stem cell-derived neural precursors grafted into the adult mammalian neostriatum. Stem Cells 27(10), 2414-2426 (2009).
27. Aubry L, Bugi A, Lefort N, Rousseau F, Peschanski M, Perrier AL. Striatal progenitors derived from human ES cells mature into DARPP32 neurons in vitro and in quinolinic acid-lesioned rats. Proc. Natl Acad. Sci. USA 105(43), 16707-16712 (2008).
28. Mombaerts P, Lacomini J, Johnson RS, Herrup K, Tonegawa S, Papaioannou VE. RAG-1-deficient mice have no mature B and T lymphocytes. Cell 68(5), 869-877 (1992).
29. Shinkai Y, Rathbun G, Lam K-P et al. RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement. Cell 68(5), 855-867 (1992).
30. Kingsley CI, Nadig SN, Wood KJ. Transplantation tolerance: lessons from experimental rodent models. Transplant Int. 20, 828-841 (2007).
31. Lund RD, Rao K, Hankin MH, Kunz HW, Gill TJ. Transplantation of retina and visual cortex to rat brains of different ages. Maturation, connection patterns, and immunological consequences. Ann. NY Acad. Sci. 495, 227-241 (1987).
32. Englund U, Fricker-Gates RA, Lundberg C, Björklund A, Wictorin K. Transplantation of human neural progenitor cells into the neonatal rat brain: extensive migration and differentiation with long-distance axonal projections. Exp. Neurol. 173(1), 1-21 (2002).
33. Pollack IF, Lund RD. The blood-brain barrier protects foreign antigens in the brain from immune attack. Exp. Neurol. 108(2), 114-121 (1990).
34. Kallur T, Darsalia V, Lindvall O, Kokaia Z. Human fetal cortical and striatal neural stem cells generate region-specific neurons in vitro and differentiate extensively to neurons after intrastriatal transplantation in neonatal rats. J. Neurosci. Res. 84(8), 1630-1644 (2006).
35. Kallur T, Farr TD, Bohm-Sturm P, Kokaia Z, Hoehn M. Spatio-Temporal dynamics, differentiation and viability of human neural stem cells after implantation into neonatal rat brain. Eur. J. Neurosci. 34(3), 382-393 (2011).
36. Zietlow R, Precious SV, Kelly CM, Dunnett SB, Rosser AE. Long-Term expansion of human foetal neural progenitors leads to reduced graft viability in the neonatal rat brain. Exp. Neurol. 235(2), 563-573 (2012).
37. Mattis VB, Wakeman DR, Tom C et al. Neonatal immunetolerance in mice does not prevent xenograft rejection. Exp. Neurol. 254, 90-98 (2014).
38. Billingham RE, Brent L. Acquired tolerance of foreign cells in newborn animals. Proc. R. Soc. Lond. B Biol. Sci. 146(922), 78-90 (1956).
39. Billingham RE, Brent L, Medawar PB. Actively acquired tolerance of foreign cells. Nature 172(4379), 603-606 (1953).
40. Adkins B, Jones M, Bu Y, Levy RB. Neonatal tolerance revisited again: specific CTL priming in mouse neonates exposed to small numbers of semi-or fully allogeneic spleen cells. Eur. J. Immunol. 34(7), 1901-1909 (2004).
41. Ridge J, Fuchs E, Matzinger P. Neonatal tolerance revisited: turning on newborn T cells with dendritic cells. Science 271, 1723-1726 (1996).
42. West LJ, Morris PJ, Wood K. Fetal liver haematopoietic cells and tolerance to organ allografts. Lancet 343(8890), 148-149 (1994).
43. Modigliani Y, Burlen-Defranoux O, Bandeira A, Coutinho A. Neonatal tolerance to alloantigens is induced by enriched antigen-presenting cells. Scand. J. Immunol. 46(2), 117-121 (1997).
44. Bandeira A, Coutinho A, Carnaud C, Jacquemart F, Forni L. Transplantation tolerance correlates with high levels of Tand B-lymphocyte activity. Proc. Natl Acad. Sci. USA 86(1), 272-276 (1989).
45. Zhang S, Jiang YZ, Zhang W et al. Neonatal desensitization supports long-Term survival and functional integration of human embryonic stem cell-derived mesenchymal stem cells in rat joint cartilage without immunosuppression. Stem Cells Dev. 22(1), 90-101 (2013).
46. Singhal S, Bhatia B, Jayaram H et al. Human Müller glia with stem cell characteristics differentiate into retinal ganglion cell (RGC) precursors in vitro and partially restore RGC function in vivo following transplantation. Stem Cells Transl. Med. 1(3), 188-199 (2012).
47. Jayaram H, Jones MF, Eastlake K et al. Transplantation of photoreceptors derived from human Müller glia restore rod function in the P23H rat. Stem Cells Transl. Med. 3(3), 323-333 (2014).
48. Janowski M, Jablonska A, Kozlowska H et al. Neonatal desensitization does not universally prevent xenograft rejection. Nat. Meth. 9(9), 856-858 (2012).
49. Kelly CM. Desensitisation of neonatal rat pups for xenotransplantation with human tissues. Protocol Exchange doi:10.1038/nprot.2009.74 (2009) (Epub ahead of print) .
50. Finsen BR, S'rensen T, Castellano B, Pedersen EB, Zimmer J. Leukocyte infiltration and glial reactions in xenografts of mouse brain tissue undergoing rejection in the adult rat brain. A light and electron microscopical immunocytochemical study. J. Neuroimmunol. 32, 159-183 (1991).
51. Armstrong RJE, Harrower TP, Hurelbrink CB et al. Porcine neural xenografts in the immunocompetent rat: immune response following grafting of expanded neural precursor cells. Neuroscience 106(1), 201-216 (2001).
52. Larsson LC, Czech KA, Brundin P, Widner H. Intrastriatal ventral mesencephalic xenografts of porcine tissue in rats: immune responses and functional effects. Cell Transplant. 9(2), 261-272 (2000).
53. Larsson LC, Anderson P, Widner H, Korsgren O. Enhanced survival of porcine neural xenografts in mice lacking CD1d1, but no effect of NK1.1 depletion. Cell Transplant. 10(3), 295-304 (2001).
54. Larsson LC, Corbascio M, Widner H, Pearson TC, Larsen CP, Ekberg H. Simultaneous inhibition of B7 and LFA-1 signaling prevents rejection of discordant neural xenografts in mice lacking CD40L. Xenotransplantation 9(1), 68-76 (2002).